News
Displaying 1–10 of 587
-
A Race Against Blindness Celebrates Recent Fundraiser Winners During Blindness Awareness Month
In the PressNonprofit highlights winners and launches its popular Build Your Own Adventure Van fundraiser to advance research for childhood blindness.
-
Emerging gene therapy for RDH12-associated Leber congenital amaurosis cleared for clinical trials
Research NewsFDA clears investigational new drug application for OPGx-RDH12 from Opus Genetics
-
Foundation Fighting Blindness Launches First-Ever National VisionWalk Day
Foundation NewsNational VisionWalk Day on October 31st will unite supporters from anywhere, raising awareness and funding research driving treatments and cures for blinding diseases.
-
Recording Available: Insights Forum | Thursday, September 24, 2026
Foundation NewsThe Foundation Fighting Blindness is pleased to provide a recording and full transcript of the Insights Forum, our quarterly conference call providing updates to the blinding diseases community. The call took place on September 24, 2026.
-
Early clinical trial results show vision gains in patients with BEST1-related disease
Research NewsOpus Genetics looks ahead to a Phase 3 trial for its potential gene therapy OPGx-BEST1
-
Protect Vision Research Funding
Advocacy Foundation NewsJoin us in the movement to protect vision research funding by reaching out to your members of Congress.
-
Beacon's emerging XLRP gene therapy improves low-light vision in phase 3 trial
Research NewsBeacon plans to begin a rolling FDA submission for laru-zova later this year
-
Nanoscope’s investigational RP treatment MOGENRY advances toward FDA approval
Research NewsOne-time injection could treat RP patients regardless of underlying genetic mutation
-
Stargardt Disease Research Advances
Research NewsRecent developments in research on Stargardt disease.
